There are many reasons to buy shares of those chipmakers, but a play on cryptocurrencies is not one of them, Jim Cramer says. » Read More
By: Evelyn Cheng
China's flagship One Belt, One Road program has far from enough financing right now, representatives from Beijing said in New York last week. » Read More
By: Cinthia Murphy, ETF.com
Active funds are bleeding assets as index funds take in trillions. But there's one area in the market where active still works: bonds. » Read More
By: Fred Imbert
Shares of Caterpillar slip after Deutsche Bank analyst Nicole DeBlase downgrades the stock. » Read More
Quarterly earnings season kicks into gear this week as reports from three big banks are set to be released on Thursday morning.
Mark 2016 as the latest 'Year of the Stock Picker' that wasn't.
Stifel upgraded Lululemon to buy from hold predicting the company will recover from its recent product mistakes.
Investors are about to see a very strong earnings season, says one strategist, who gives his take on what to expect.
A rare condition known as "backwardation" speaks to traders' anxiety over the upcoming French election.
Expectations for Wall Street are high as stocks have stalled near record highs, USA Today reports.
Shares of Tractor Supply fall after the company reported disappointing same-store sales results to start the year.
One of the most popular post-election trades just lost all its 2017 gains.
The report comes days after activist investor Jana Partners took nearly a 9% stake.
Here's the full interview of Rafferty Capital Markets’ Dick Bove on CNBC's "Squawk Box."
A popular gold miner ETF is finding it difficult to match its index after $4 billion from investors poured in amid the big bullion rally.
Neurocrine says the FDA has approved Ingrezza, the only drug for treatment of adults with tardive dyskinesia.
Here's the problem: a lot is expected to go right with bank earnings.
Jim Cramer looks to Bob Lang's charts to reveal major biotech names that are rallying despite Washington's drug pricing controversy.
After a horrendous plunge, one retail stock is beating a striking comeback.
Bank of America Merrill Lynch added Hess to the firm's US1 best ideas list.
As quarterly earnings season kicks into gear this week, no sector will be more important than banks.
Mylan said production at its Nashik site continues uninterrupted at this time.
Canada's potential marijuana legalization could lure cannabis connoisseurs from the United States, NBC News reports.
Brazilian airline Azul opened at $22 per share in its market debut on Tuesday.
Get the best of CNBC in your inbox